Target intelligence / Profile preview

Axonal membrane lipid bilayer

Molecular classification
Lipid bilayer, Cellular membrane
01

Overview

The axonal membrane lipid bilayer, also known as the axolemma, is a specialized plasma membrane that encapsulates the axon and is critical for the conduction of action potentials and the maintenance of axonal homeostasis (Bittner et al., 2012). Following a traumatic peripheral nerve injury, the disruption of this lipid bilayer leads to the loss of electrical continuity and initiates Wallerian degeneration of the distal nerve segment (Ghergherehchi et al., 2019). This structure is targeted by chemical fusogens, such as polyethylene glycol (PEG), which act to physically reconnect the severed ends of the axonal membranes. PEG functions by removing the hydration shell from the phospholipid head groups, allowing the lipid bilayers of the proximal and distal stumps to fuse upon contact (Riley et al., 2015). This therapeutic intervention, often referred to as PEG-fusion, aims to restore immediate axonal continuity and prevent the degradation of the distal nerve segment, thereby improving functional recovery outcomes in patients with severe nerve lacerations (Bittner et al., 2016).

Other names
AxolemmaAxonal membraneSevered axonal endsNerve stump membranes
02

Mechanism of action

Membrane fusion and sealing via chemical fusogens that dehydrate lipid head groups, allowing the lipid bilayers of severed axonal ends to merge and restore cytoplasmic continuity.

03

Biological functions

Signal transductionCellular compartmentalizationIon homeostasisAction potential propagation
04

Disease associations

Peripheral nerve injuryAxonal degenerationTraumatic neuropathy
05

Safety considerations

Potential for axonal mis-targetingIncomplete fusionLocal tissue irritationSystemic toxicity at high concentrations
06

Interacting drugs

Polyethylene glycol

1 more in the full profile.

07

Biomarkers

Compound Muscle Action Potential (CMAP)Somatosensory Evoked Potentials (SSEP)Axonal continuity

Beyond the preview

Go deeper on Axonal membrane lipid bilayer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axonal membrane lipid bilayer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call